Effect of Blue Light Glasses on Screen Usage After a Concussion in College Students

Last updated: March 19, 2021
Sponsor: Rochester Institute of Technology
Overall Status: Active - Recruiting

Phase

N/A

Condition

Brain Injury

Treatment

N/A

Clinical Study ID

NCT04804501
RochesterIT
  • Ages 18-26
  • All Genders

Study Summary

Premature cessation of screen usage is a common behavior post-concussion, given the taxing nature of a screen-time task. In the academic setting, screen-time is a near unavoidable component, however, complete avoidance of class and screen use may in fact provoke psychological symptoms of anxiety and depression in students, for fear of falling behind in their studies. Thus, compensatory measures should be investigated to assist students as they attempt to maintain academic involvement throughout their concussion recovery. Blue light blocking glasses have been shown to significantly increase screen-time usage in individuals with post-concussion syndrome, yet these results are only representative of a small portion of the concussion population. Thus, we propose investigating whether blue light blocking glasses can prolong screen usage prior to symptom exacerbation, specifically in concussed students that are still within the normal recovery timeframe. This cross-sectional randomized clinical trial will provide further evidence of the utility blue light blocking glasses can offer as a therapeutic tool for students recovering from concussion. We would like to test volunteers from the Rochester Institute of Technology who have been treated by a medical provider within the university's health center. Blue light glasses will be worn during a one-time computer reading task while the subject is participating in the study. The total time for the complete the reading task is dependent upon the participant's symptom fluctuations; however, we suspect completion criteria will be met within 20 minutes from beginning. The risks in this study are minimal and results may increase our understanding of therapeutic tools for patients with ocular-driven concussion symptoms.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Full-time student at RIT
  • Diagnosed mild traumatic brain injury
  • Between 18-26 years of age
  • Within 3-14 days post-injury

Exclusion

Exclusion Criteria:

  • Any head, neck, or face injury in the 1 year prior to the study (e.g., concussion, eyeinjury) other than the current injury
  • History of vestibular or ocular dysfunction\
  • Any neurological disorders (e.g., seizure disorders, closed head injuries with loss ofconsciousness greater than 15 minutes, CNS neoplasm, history of stroke)
  • Injury more severe than mild traumatic brain injury (skull fracture, positive CT orMRI)
  • Having taken pain medication within 8 hours prior to testing
  • Not able to personally consent
  • Pregnant
  • Deaf or hard of hearing.

Study Design

Total Participants: 64
Study Start date:
March 01, 2021
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • Rochester Institute of Technology

    Rochester, New York 14623
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.